| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.38B | 138.18B | 137.91B | 139.49B | 127.64B | 107.00B |
| Gross Profit | 39.17B | 37.28B | 36.51B | 34.03B | 33.74B | 25.39B |
| EBITDA | 15.43B | 15.35B | 15.52B | 13.75B | 14.07B | 7.35B |
| Net Income | 12.43B | 12.94B | 11.48B | 10.02B | 9.07B | 2.81B |
Balance Sheet | ||||||
| Total Assets | 224.74B | 198.31B | 202.07B | 180.59B | 163.56B | 154.91B |
| Cash, Cash Equivalents and Short-Term Investments | 22.41B | 16.61B | 21.34B | 14.60B | 14.17B | 12.26B |
| Total Debt | 32.80B | 6.55B | 2.97B | 12.79B | 6.75B | 8.18B |
| Total Liabilities | 64.10B | 47.45B | 54.10B | 51.62B | 44.76B | 40.91B |
| Stockholders Equity | 159.66B | 149.98B | 147.10B | 128.19B | 118.12B | 110.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.79B | 16.72B | -5.57B | 8.01B | -527.00M |
| Operating Cash Flow | 0.00 | 2.02B | 22.04B | -213.00M | 12.84B | 5.90B |
| Investing Cash Flow | 0.00 | -5.26B | -3.24B | -3.52B | -5.82B | -7.60B |
| Financing Cash Flow | 0.00 | -3.03B | -13.49B | 3.31B | -5.39B | 1.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥178.28B | 12.04 | 8.27% | 2.68% | -2.45% | 7.31% | |
78 Outperform | ¥540.47B | 12.74 | 13.63% | 1.95% | -1.33% | 9.21% | |
75 Outperform | ¥144.74B | 9.78 | ― | 2.66% | -1.63% | 67.13% | |
72 Outperform | ¥4.42B | 6.43 | ― | 2.79% | 3.32% | 18.84% | |
71 Outperform | ¥1.07T | 16.83 | 7.53% | 3.13% | 1.90% | -6.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥318.97B | -15.81 | -20.43% | 3.72% | -8.20% | ― |